Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.

Van Cutsem, E

Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group. [electronic resource] - Seminars in oncology Feb 1999 - 13-20 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

0093-7754


Antimetabolites, Antineoplastic--therapeutic use
Antineoplastic Agents, Phytogenic--therapeutic use
Camptothecin--analogs & derivatives
Colorectal Neoplasms--drug therapy
Female
Fluorouracil--therapeutic use
Humans
Irinotecan
Male
Middle Aged
Multivariate Analysis
Neoplasm Metastasis
Quality of Life
Survival Analysis
Topoisomerase I Inhibitors
Treatment Failure